get the top three things to know in women's health + wellness, every weekday:

Could Ozempic Prevent Fibroids?

What: An analysis of over 30,000 women with type 2 diabetes found that those who got a GLP-1 medication, like Ozempic, were 27% less likely to develop new fibroids than women who just took metformin, a diabetes medication.

Key line: “In women with type 2 diabetes, GLP-1 receptor agonists may protect against new-onset uterine fibroids compared to both metformin and insulin,” Hsieh said. “We recommend further research, including prospective cohorts and basic research, to understand the underlying therapeutic mechanisms.”

Source: American Society for Reproductive Medicine // https://www.healio.com/news/womens-health-ob-gyn/20241028/glp1-drugs-may-reduce-uterine-fibroid-risk-for-women-with-type-2-diabetes

More News Snippets
The Birth Rate Fallacy

Experts explaining that the global drop in fertility rates is partly a product of women having children later in life.

To Prevent the Cancer from Returning

An essay from Rachel Manteuffel on her breast cancer diagnosis and treatment that manages to be funny while also tackling the wrenching choice to have chemotherapy or not after a mastectomy.

Another Mother Dead Thanks to Abortion Bans

Josseli Barnica was excited to be pregnant with her second child but suffered a miscarriage at 17 weeks. Instead of helping the miscarriage progress, doctors let her suffer for 40 hours because her fetus still had a heartbeat.

Could Ozempic Prevent Fibroids?

Women with type 2 diabetes who got a GLP-1 medication were less likely to develop new fibroids than women who just took metformin, a diabetes medication.